semaglutide and leptin GLP-1RAs attenuated obesity reversed resistance partly via activating the microbiome-derived inosine/A2A pathway Effect of Submaximal Doses of

This cross talk is part of why the peptide may help during aging and high training loads

Increased body weight with obesity affects insulin sensitivity, glucose intolerance, cerebral blood flow, aging progression, and susceptibility to infection, such as with coronavirus disease 2019 (COVID-19) in DM patients

However, it had no effect on physical performance

Consumers should verify the current status of this proposal at FDA.gov before enrolling in any compounded GLP-1 program, and ask their assigned provider which compounding pathway applies to their prescription and what specific clinical justification will be documented

For a deeper dive into semaglutide specifically, see our companion article, the Semaglutide Research Guide

While some patients achieve permanent clearance, others may require maintenance treatments